TY - JOUR
T1 - A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype
AU - Brunssen, Alicia
AU - GEKID Cancer Survival Workgroup
AU - Jansen, Lina
AU - Eisemann, Nora
AU - Waldmann, Annika
AU - Weberpals, Janick
AU - Kraywinkel, Klaus
AU - Eberle, Andrea
AU - Holleczek, Bernd
AU - Zeissig, Sylke Ruth
AU - Brenner, Hermann
AU - Katalinic, Alexander
AU - Geiss, Karla
AU - Meyer, Martin
AU - Luttmann, Sabine
AU - Stabenow, Roland
AU - Hentschel, Stefan
AU - Nennecke, Alice
AU - Kieschke, Joachim
AU - Sirri, Eunice
AU - Emrich, Katharina
AU - Kajüter, Hiltraud
AU - Mattauch, Volkmar
N1 - Copyright © 2018 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Background: Differences in relative survival (RS) of melanoma between histologic subtypes were discussed to be mainly caused by tumor thickness. Objective: To investigate RS of melanoma, stratified by tumor thickness for each histologic subtype, and identify survival trends. Methods: With use of cancer registry data on melanoma cases (International Classification of Diseases, 10th Revision, codes C43.0–C43.9) diagnosed in Germany in 1997–2013, 5- and 10-year age-standardized RS stratified by histologic subtype and stratified or standardized by T stage was estimated by standard and modeled period analyses. We restricted 10-year RS analyses to patients younger than 75 years. Results: We analyzed 82,901 cases. Overall, the 5- and 10-year RS rates were 91.7% and 90.8%, respectively. Prognosis worsened with increasing T stage for all histologic subtypes, but T-stage distribution varied substantially. Survival differences by histologic subtype were strongly alleviated after adjustment for T stage but remained significant. Overall, 5-year RS increased significantly (by 3.8 percentage points) between the periods 2002–2005 and 2010–2013. This increase was no longer seen after adjustment for T stage. Limitations: Exclusion of cases on account of missing information on T stages, changes in the definition of T stages, and lack of information on screening and treatment limit our analyses. Conclusion: Differences in RS between histologic subtypes were strongly mediated by tumor thickness. Over time, RS of melanoma increased as a result of changes in T-stage distribution.
AB - Background: Differences in relative survival (RS) of melanoma between histologic subtypes were discussed to be mainly caused by tumor thickness. Objective: To investigate RS of melanoma, stratified by tumor thickness for each histologic subtype, and identify survival trends. Methods: With use of cancer registry data on melanoma cases (International Classification of Diseases, 10th Revision, codes C43.0–C43.9) diagnosed in Germany in 1997–2013, 5- and 10-year age-standardized RS stratified by histologic subtype and stratified or standardized by T stage was estimated by standard and modeled period analyses. We restricted 10-year RS analyses to patients younger than 75 years. Results: We analyzed 82,901 cases. Overall, the 5- and 10-year RS rates were 91.7% and 90.8%, respectively. Prognosis worsened with increasing T stage for all histologic subtypes, but T-stage distribution varied substantially. Survival differences by histologic subtype were strongly alleviated after adjustment for T stage but remained significant. Overall, 5-year RS increased significantly (by 3.8 percentage points) between the periods 2002–2005 and 2010–2013. This increase was no longer seen after adjustment for T stage. Limitations: Exclusion of cases on account of missing information on T stages, changes in the definition of T stages, and lack of information on screening and treatment limit our analyses. Conclusion: Differences in RS between histologic subtypes were strongly mediated by tumor thickness. Over time, RS of melanoma increased as a result of changes in T-stage distribution.
UR - http://www.scopus.com/inward/record.url?scp=85060985236&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2018.09.018
DO - 10.1016/j.jaad.2018.09.018
M3 - Journal articles
C2 - 30244061
AN - SCOPUS:85060985236
SN - 0190-9622
VL - 80
SP - 938
EP - 946
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 4
ER -